Nexalin Technology unveils positive results of clinical study for Gen-2 tACS device

Investor Relations, Videos

April 18, 2024 12:07 PM

Link to site HERE.

Nexalin Technology Enrolls First Patients and Advances Toward Treatment in UCSD Clinical Trial

April 2, 2025

Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on April 3

March 26, 2025

Nexalin Technology Receives Notice of Allowance from the USPTO for Patent Covering Deep Intracranial Frequency Stimulation (DIFS™) Technology for Opioid and Other Substance Use Disorders

March 3, 2025